Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 0 | 0 | 0 | 0 |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | 7.8M | 7.3M | 5.0M | 10.7M |
Selling general and admin | 10.0M | 8.1M | 7.2M | 7.1M |
Other operating expenses | — | — | — | — |
Operating income | -17.9M | -15.4M | -12.3M | -17.8M |
Non operating interest income | ||||
Income | 3.7M | 3.3M | 2.5M | 1.7M |
Expense | — | — | — | — |
Other income expense | — | 2.1M | — | -13.1M |
Pretax income | -14.2M | -10.0M | -9.7M | -29.2M |
Tax provision | -4.4M | 294.4K | 225.0K | 163.6K |
Net income | -9.8M | -10.3M | -10.0M | -29.3M |
Basic EPS | -0.1 | — | -0.1 | -5.2 |
Diluted EPS | -0.1 | — | -0.1 | -5.2 |
Basic average shares | 138.1M | — | 122.1M | 100.0M |
Diluted average shares | 138.1M | — | 122.1M | 100.0M |
EBITDA | -17.8M | -17.3M | -12.2M | -4.6M |
Net income from continuing op. | -9.8M | -10.3M | -10.0M | -29.3M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |